Ingevity Corp
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings (Loss) per Share
Index
Note 19: Earnings (Loss) per Share
| Years Ended December 31, | |||
|---|---|---|---|
| In millions (except share (in thousands) and per share data) | 2025 | 2024 | 2023 |
| Net income (loss) from continuing operations | $(150.3) | $(121.4) | $105.8 |
| Net income (loss) from discontinued operations | (16.8) | (308.9) | (111.2) |
| Net income (loss) | $(167.1) | $(430.3) | $(5.4) |
| Basic and Diluted earnings (loss) per share | |||
| Basic earnings (loss) per share from continuing operations | $(4.15) | $(3.34) | $2.90 |
| Basic earnings (loss) per share from discontinued operations | (0.46) | (8.51) | (3.05) |
| Basic earnings (loss) per share (1) | $(4.61) | $(11.85) | $(0.15) |
| Diluted earnings (loss) per share from continuing operations | $(4.15) | $(3.34) | $2.88 |
| Diluted earnings (loss) per share from discontinued operations | (0.46) | (8.51) | (3.03) |
| Diluted earnings (loss) per share (1) | $(4.61) | $(11.85) | $(0.15) |
| Shares | |||
| Weighted average number of shares of common stock outstanding - Basic | 36,222 | 36,323 | 36,496 |
| Weighted average additional shares assuming conversion of potential common shares (2) | — | — | 210 |
| Shares - diluted basis | 36,222 | 36,323 | 36,706 |
(1) Diluted earnings (loss) per share is calculated using net income (loss) available to common stockholders divided by diluted weighted average shares of common shares outstanding during each period, which includes the dilutive effect of outstanding equity awards.
(2) For the years ended December 31, 2025 and 2024, all potentially dilutive common shares were excluded from the calculation of diluted earnings (loss) per share as we had a net loss from continuing operations for the period.
The following average number of potential common shares were antidilutive and, therefore, were not included in the diluted earnings per share calculation:
| Years Ended December 31, | |||
|---|---|---|---|
| In thousands | 2025 | 2024 | 2023 |
| Average number of potential common shares - antidilutive | 654 | 444 | 361 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.